Guess which ASX 200 healthcare stock is surging 8% on record sales

This medical device company's sales growth was strong in November.

| More on:
Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Polynovo Ltd (ASX: PNV) shares have come flying out of the gates on Wednesday.

In morning trade, the ASX 200 healthcare stock is up 8% to $1.45.

Why is this ASX 200 healthcare stock jumping?

Investors have been scrambling to buy PolyNovo's shares today after it achieved a record month of sales in November.

According to the release, the company reported unaudited sales of $8 million for the month. This was driven by strong growth in both the United States and its Rest of World businesses.

The U.S. business reported monthly sales of $6.1 million, which was an increase of 74% on the same time last year.

Whereas the ASX 200 healthcare stock's Rest of World business grew its sales even stronger, albeit from a small base. It reported sales of $2.7 million for the month, which is an increase of 290% on the prior corresponding period. Management notes that there was strong growth in the UK and Ireland, ANZ, and the Middle East regions.

Total group revenue for the month, including BARDA was $9.5 million, which is up ~110% year on year.

'Redefine healing across the world'

The ASX 200 healthcare stock's CEO, Swami Raote, was pleased with the month. He said:

NovoSorb BTM continues to redefine healing across the world. Clinicians are taking advantage of its simplicity and versatility to manage complex wounds effectively. We are grateful to our surgeons, for their support in driving innovation and education as evidenced by over 237 publications across multiple indications. We are gaining momentum, with over 34,900 patients treated so far. As proud as we are of our progress, we are working hard to reach and touch many more lives with this disruptive technology platform.

The PolyNovo share price remains down over 20% since this time last year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PolyNovo. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

Why is this ASX 200 pharmaceuticals stock crashing 15% today?

Investors haven't responded positively to a sales update.

Read more »

A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.
Share Gainers

This small-cap ASX stock just rocketed 39%. What's doing?

A stock no one has heard of is lighting up trading screens on Wednesday. You might hear this name more…

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Has the CSL share price got further to fall?

ASX experts weigh in on what's next for CSL.

Read more »

Shot of a young scientist using a laptop while conducting research in a laboratory.
Healthcare Shares

2 popular ASX 200 healthcare shares tanking on earnings updates

Let's check out the earnings reports from these two ASX 200 healthcare shares today.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Hoping to bag the record Medibank dividend? Here's what you need to do

Time is running out if you'd like to bank the ASX 200 healthcare stock's largest-ever dividend.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Earnings Results

Nanosonics share price crashes 14% on first-half profit crunch

Investors haven't responded positively to the release of the company's half-year results.

Read more »

Three excited business people cheer around a laptop in the office
Healthcare Shares

Here's why ResMed shares can jump a further 20%

Investors have done very well from this stock recently. The good news is that analysts expect the trend to continue.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Share Gainers

If you'd put $20,000 in this ASX healthcare stock during COVID-19, you'd have $257,000 now

You could have become filthy rich in just 4 years. Just think about that.

Read more »